Galecto Inc
NASDAQ:GLTO
Galecto Inc
Other Current Assets
Galecto Inc
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Galecto Inc
NASDAQ:GLTO
|
Other Current Assets
$859k
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genmab A/S
CSE:GMAB
|
Other Current Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Other Current Assets
kr28m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
19%
|
CAGR 10-Years
23%
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Other Current Assets
€42.5m
|
CAGR 3-Years
41%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Other Current Assets
kr47.9m
|
CAGR 3-Years
36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
13%
|
Bioporto A/S
CSE:BIOPOR
|
Other Current Assets
kr3.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Galecto Inc's Other Current Assets?
Other Current Assets
859k
USD
Based on the financial report for Dec 31, 2023, Galecto Inc's Other Current Assets amounts to 859k USD.
What is Galecto Inc's Other Current Assets growth rate?
Other Current Assets CAGR 3Y
-22%
Over the last year, the Other Current Assets growth was -5%. The average annual Other Current Assets growth rates for Galecto Inc have been -22% over the past three years .